A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer-Reference-Cited by-同舟云学术

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

Published:2011-01 Issue:1 Volume:13 Page:98-107
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Geller Melissa A.,Cooley Sarah,Judson Patricia L.,Ghebre Rahel,Carson Linda F.,Argenta Peter A.,Jonson Amy L.,Panoskaltsis-Mortari Angela,Curtsinger Julie,McKenna David,Dusenbery Kathryn,Bliss Robin,Downs Levi S.,Miller Jeffrey S.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference55 articles.

1. Role of monocytes in the expansion of human activated natural killer cells;Miller;Blood,1992

2. The generation of human natural killer cells from CD34+/DR− primitive progenitors in long-term bone marrow culture;Miller;Blood,1992

3. Population dynamics of human activated killer cells in culture;Pierson;Biotech Bioeng,1994

4. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor;Miller;Blood,1994

5. Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy;Miller;Bone Marrow Transplant,1994

Cited by 359 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An improved approach to generate IL-15+/+/TGFβR2−/− iPSC-derived natural killer cells using TALEN;Cell Reports Methods;2024-09

2. Adoptive T cell therapy for ovarian cancer;Gynecologic Oncology;2024-07

3. Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas;Vaccines;2024-06-18

4. Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies;Biological Chemistry;2024-05-21

5. Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics;Frontiers in Immunology;2024-03-12